When I look at India’s journey through the lens of bioeconomy, I don’t just see numbers, policies, or growth rates. I see a civilisation that has always believed in the quiet power of nature, from Ayurveda’s herbal wisdom to the farmer sowing seeds on his ancestral land. Today, what was once intuitive knowledge has been reborn with the language of laboratories, genome sequencing, and AI-driven bioinformatics. And this blend of tradition and technology is what makes India’s bioeconomy a story worth telling.
Every morning, as the sun touches the fields of Uttar Pradesh or the labs of Bengaluru, I imagine the invisible threads connecting a centuries-old herbal remedy, a genetically improved crop, and a cutting-edge vaccine vial. Each of these threads tells a story of resilience, innovation, and a nation learning to turn its biological wealth into a sustainable future.
The Bioeconomy is defined as “the production, use, and conservation of biological resources, including related knowledge, science, technology, and innovation, to provide information, products, processes, and services to all economic sectors with the aim of moving towards a sustainable economy,” by the United Nations Food and Agriculture Organisation. In simpler terms, bioeconomy is about transforming life’s building blocks, plants, microbes, and animals, into solutions for health, energy, agriculture, and industry.
Across the globe, the bioeconomy has become both an economic and strategic priority. Europe, for instance, already derives over 20% of GDP from bio-based sectors, while India’s bioeconomy is rapidly expanding, currently contributing around 4.2% of GDP and projected to reach $300 billion by 2030. The contrast is telling: while Europe’s bioeconomy shows maturity, India demonstrates potential, dynamism, and ambition. India’s bioeconomy is composed of multiple interlinked sectors. Industrial biotechnology from biofuels to enzymes and bioplastics leads the value chain, generating nearly half of the total bioeconomic output. BioPharma follows closely, driven by India’s vaccine production and therapeutics, while bio-services, research, and bio-agriculture are emerging rapidly.
The numbers are impressive. From $86 billion in 2020, India’s bioeconomy nearly doubled to $165 billion by 2024. More than 10,000 companies now operate in the sector, employing millions and contributing to global innovation. BIRAC alone has supported over 800 products, 1,300 IP filings, and Rs 5,500 crore in investments.Yet behind these numbers is a narrative of resilience. Consider the 1,128 startups formed in 2021 or the 1,544 new ventures in 2024. Each represents not just innovation, but a vision: turning biology into economy, traditional knowledge into high-tech solutions, and local resources into global impact.
India’s bioeconomy is unique because it bridges millennia of knowledge with 21st-century innovation. Take Ayurveda, for example, centuries-old herbal formulations are now being studied with modern genomics and biotechnology to validate efficacy, standardise dosage, and create global therapeutic products. Similarly, agricultural biotechnology builds on traditional farming wisdom, introducing drought-resistant crops, biofertilizers, and Bt Cotton to enhance yield while reducing chemical use.
Vaccines offer another example. India’s global leadership in vaccine manufacturing, demonstrated during the COVID-19 pandemic, reflects not only scientific capability but an ability to translate research into public health impact. Over 4 million doses were administered daily in 2021, a feat requiring logistics, regulatory efficiency, and scientific excellence. And this is only the beginning: advanced vaccines like PneumoShield 14, HILLCHOL, and Cadiflu Tetra show India is now innovating solutions for global health challenges.
The bioeconomy is not just about production; it is about responsibility. Circular bioeconomy principles, reuse, repair, and recycle are embedded in the Indian approach. From converting agricultural residues into ethanol for biofuel to designing biodegradable packaging, India is embracing solutions that reduce environmental impact while creating economic value. The ethanol blending program, for example, has advanced India’s target from 2025 to 2023, producing 16.2 billion litres of bioethanol and reducing fossil fuel dependency. Similarly, biofertilizers and biopesticides are gradually replacing chemical inputs, promoting soil health and climate resilience.
India’s bioeconomy does not operate in isolation. Global collaborations, such as the Global Biofuel Alliance (GBA) with the US and Brazil, and the Ind-CEPI mission for epidemic vaccine development, position India as a global partner in sustainable solutions. Scientific breakthroughs such as the GenomeIndia Project, indigenous CAR-T cell therapies, and antibiotics against antimicrobial resistance exemplify India’s growing capabilities. Marine and space biotechnology, though niche, reflect India’s visionary approach. From bio-prospecting marine microorganisms to exploring bio-manufacturing in microgravity, the nation is pushing boundaries where science meets imagination. And in the skies, drone-based healthcare delivery in Kerala illustrates how bioeconomy innovations can directly improve lives, reducing delivery times from hours to minutes.
India’s bioeconomy is a testament to what a nation can achieve when tradition, technology, and policy converge. It addresses climate change, reduces reliance on fossil fuels, ensures food and health security, and generates millions of jobs. By 2030, the sector is projected to employ 35 million people, turning young innovators into agents of sustainable progress. Yet challenges remain. Regulatory uncertainty, underdeveloped infrastructure in eastern and northeastern regions, slow adoption of genetically modified crops, and gaps in commercialisation need attention. Awareness and skill development are critical to ensure that innovations reach farmers, industries, and global markets.
Looking ahead, the path is both exciting and demanding. By 2030, India’s bioeconomy could touch nearly every sector from agriculture to healthcare to industrial manufacturing and help achieve energy security, environmental resilience, and economic self-reliance. And that, perhaps, is the most visionary part of this journey: bioeconomy is not just about GDP or exports, it is about embedding sustainability into the rhythm of daily life, turning biology into both purpose and promise. When I step back and see the bigger picture, I realise that India’s bioeconomy is more than an economic concept — it is a reflection of a civilisation that has long revered life in all its forms. It is a story of nature and nurture, tradition and innovation, patience and audacity. And in that story, the nation is learning not only to thrive but to do so wisely, sustainably, and boldly.
Every breakthrough, every startup, every policy is a note in a grand composition where scientific insight meets care for the environment, and economic growth respects and uplifts communities. The promise of tomorrow is encoded not just in laboratories and boardrooms but in DNA, yet grounded in soil, water, and centuries of tradition. India’s bioeconomy reflects our curiosity, courage, and commitment to innovate while staying rooted. DNA and soil, AI and tradition, past and future all converge to paint a vision of a nation that dares to dream sustainably. And that, perhaps, is the truest measure of progress: a country where innovation flows from heritage, growth respects the earth, and every scientific breakthrough carries the weight of responsibility, hope, and promise.